Trinity Biotech | TRIB - Betriebsaufwand





Betriebsaufwand Veränderung Datum
Abbott USD 9.31B 104M 2026-03
Bayer EUR 9.88B 452M 2026-03
Bio-Rad Laboratories USD 6.85B 6.21B 2026-03
EDAP TMS EUR 18.8M 3.01M 2025-09
J&J USD 17.44B 1.53B 2026-03
Mesa Laboratories USD 33.98M 2.03M 2024-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Plus Therapeutics USD 7.11M 1.23M 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Siemens EUR 16.57B 2.29B 2025-12
Surmodics USD 29.51M 274.86M 2025-06
Thermo Fisher Scientific USD 9.09B 821M 2026-03
Tosoh JPY 238.2B 6.41B 2026-03
Trinity Biotech USD 14.82M 7.81M 2025-09
Veracyte USD 119.99M 3.99M 2026-03